Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care

Part of paid clinical trials in Durham, North Carolina.

Sponsor
Duke University
Study ID
NCT07738874
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Retinopathy of Prematurity (ROP)

Eligibility Criteria

Sex
ALL
Age
0 Days - 9 Months
Healthy Volunteers
Not accepted

Interventions

  • Ultra-widefield Optical Coherence Tomography (UWF-OCT) — DEVICE
    Handheld retinal OCT imaging at the bedside or in clinic with an ultra-widefield handheld optical coherence tomography
  • Wide-field ophthalmic imaging system — DEVICE
    Handheld wide-field ophthalmic fundus imaging at the bedside or in clinic

Study Details

Retinopathy of prematurity (ROP) is a disorder of development of the retina and its vasculature that can impact vision in vulnerable preterm neonates for a lifetime. A major barrier to improving ROP outcomes is the lack of easy access and low stress means to obtain objective measures of ROP disease severity across the retina in these infants. The long-term goal of this program is to provide information which will improve preterm infant health and vision via objective bedside imaging and analysis that characterizes retina-wide ROP level of disease, its response to treatment and development, and to rapidly translate this for better early intervention and improved future vision care.

Key Dates

First listed
Jul 31, 2026
Start date
Jul 1, 2026
Status verified
Jul 2026
Primary completion
Jun 30, 2031
Completion
Dec 31, 2031

Study Design

Enrollment
175 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Test bedside UWF-OCT versus bionocular indirect ophthalmoscopic exam to identify RW-ROP and TR-ROP
    175 infants at risk for retinopathy of prematurity will be enrolled and have beside ultra-widefield OCT retinal imaging and standard-of-care binocular indirect ophthalmoscopic (BIO) exam.
  • Experimental: Test bedside UWF-OCT versus fundus photos to identify RW-ROP and TR-ROP
    455 infants at risk for retinopathy of prematurity: 175 infants will be enrolled and have beside ultra-widefield OCT retinal imaging, fundus imaging, and binocular indirect ophthalmoscopic exam. Data from newly enrolled infants will be combined with 280 infants who had similar imaging in BabySTEPS1, BabySTEPS2, and the Duke Investigational Pediatric OCT study to perform artificial intelligence (AI) based RW-ROP and TR-ROP severity assessment and to add OCT risk measures to AI-based prediction of RW-ROP and TR-ROP.
  • Experimental: Test UWF-OCT versus binocular indirect ophthalmoscopic exam to characterize ROP regression
    45 infants treated for ROP: Compare OCT measures to clinical findings of ROP regression and identify early signs of ROP reactivation.

Primary Outcome Measure

Sensitivity and specificity of ultra-widefield OCT vs bionocular indirect ophthalmoscopy or fundus photograph to identify referral-warranted retinopathy of prematurity [ Time Frame: Up to 60 weeks post-menstrual age ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Duke University Eye CenterDurhamNorth Carolina27705
Xi Chen, MD, PhD
919-684-8434
Michelle N McCall, MCAPM, BA
919-684-0544
Xi Chen, MD, PhD (PRINCIPAL_INVESTIGATOR)
Cynthia A Toth, MD (SUB_INVESTIGATOR)
Sharon F Freedman, MD (SUB_INVESTIGATOR)
Sasapin G Prakalapakorn, MD (SUB_INVESTIGATOR)
Roarke Horstmeyer, PhD (SUB_INVESTIGATOR)
University of Pennsylvania, Center for Preventive Ophthalmology and BiostatisticsPhiladelphiaPennsylvania19104-

Find similar trials in Durham, NC

Related Studies